Agatha Inc.

Based in Japan, Agatha Inc. is a provider of tailored document management solutions focused on the healthcare and life sciences sectors, enhancing operational efficiency and compliance for its clients. Founded in 2015 in Tokyo, Japan, Agatha Inc. specializes in document management solutions for the healthcare and life sciences sectors.

The company has raised a total of JPY 360. 000 mn through various rounds, with the most recent being a Series B round led by One Capital on April 10, 2025. The current valuation of Agatha Inc. is JPY 3,010.

725 mn. Ahmed Nafkha is the founder of the company, while Chiemi Kamakura serves as the CEO. Agatha Inc. specializes in providing tailored document management solutions specifically for the healthcare and life sciences sectors.

Their core offerings include Agatha Basic, Agatha eTMF, Agatha CTMS, and Agatha QMS, designed to enhance operational efficiency and compliance within medical and pharmaceutical environments. The products facilitate the management of clinical trial documents, standard operating procedures, and quality management systems, addressing challenges such as regulatory compliance, data security, and workflow optimization. Agatha has garnered a diverse clientele that includes over 1,100 healthcare institutions, pharmaceutical companies, and research organizations across international markets such as Japan, North America, and Europe. The company’s focus on high security and flexibility in its solutions distinguishes it from generic cloud file management systems.

Agatha Inc. generates revenue primarily through subscription-based models for their document management solutions. Clients typically engage with the company through direct partnerships, enabling them to utilize a range of products tailored to their specific operational needs. Each product, such as Agatha eTMF or Agatha QMS, offers varying features that cater to distinct aspects of document management in regulated environments.

Pricing structures are designed to accommodate the diverse budgets of pharmaceutical and healthcare organizations, ensuring accessibility while delivering high-value benefits. The company's commitment to customer support and training further solidifies relationships with clients, contributing to sustained usage and satisfaction across its product offerings. In April 2025, Agatha Inc. raised an undisclosed amount in venture funding from new investor ARCHIMED.

This funding will be used to accelerate the company's global expansion. Agatha Inc. intends to introduce new products designed to enhance its offerings in the document management sector, although specific release dates have not yet been announced. The company aims to target new markets in Europe and North America by the end of 2025.